Pages that link to "Q34598268"

The following pages link to Structure-based development of specific inhibitors for individual cathepsins and their medical applications (Q34598268):

Displaying 21 items.

• Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate (Q26782938) (← links)
• Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes (Q26827307) (← links)
• Identification of semicarbazones, thiosemicarbazones and triazine nitriles as inhibitors of Leishmania mexicana cysteine protease CPB (Q28534433) (← links)
• Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments. (Q35906413) (← links)
• Cathepsin L targeting in cancer treatment. (Q36218199) (← links)
• Discovery of Reactive Microbiota-Derived Metabolites that Inhibit Host Proteases (Q36256794) (← links)
• Microbial and fungal protease inhibitors--current and potential applications (Q37973268) (← links)
• The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles (Q37998958) (← links)
• Cancer-associated lysosomal changes: friends or foes? (Q38025001) (← links)
• Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges (Q38268345) (← links)
• Calpain research for drug discovery: challenges and potential (Q39004902) (← links)
• Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases (Q39067283) (← links)
• Cathepsin L silencing enhances arsenic trioxide mediated in vitro cytotoxicity and apoptosis in glioblastoma U87MG spheroids (Q39106632) (← links)
• Streptococcus oralis Induces Lysosomal Impairment of Macrophages via Bacterial Hydrogen Peroxide (Q40699809) (← links)
• Caging the uncageable: using metal complex release for photochemical control over irreversible inhibition (Q42380738) (← links)
• Ru(ii) polypyridyl complexes as photocages for bioactive compounds containing nitriles and aromatic heterocycles (Q50091548) (← links)
• Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report. (Q51498595) (← links)
• Affinity-Enhanced Luminescent Re(I)- and Ru(II)-Based Inhibitors of the Cysteine Protease Cathepsin L. (Q55474273) (← links)
• Identification of proteins with potential osteogenic activity present in the water-soluble matrix proteins from Crassostrea gigas nacre using a proteomic approach. (Q55530715) (← links)
• Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway (Q87421342) (← links)
• Cysteine-type cathepsins promote the effector phase of acute cutaneous delayed-type hypersensitivity reactions (Q91690107) (← links)